Skip to content

Public FDA record

Z-2485-2025: Superion IDS Kit Superion Indirect Decompression System 8MM, VF Implant 101-9808 00884662000529 Superion

Recall record Z-2485-2025 for Boston Scientific Neuromodulation Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2485-2025
Company in FDA record
Boston Scientific Neuromodulation Corporation
FDA classification date
Sep 2, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

As a result of a comprehensive product performance review it was determine that the device and instruments are not consistently meeting expected performance levels. Issues include breakage of the instruments and implant/device.

Source facts

Action
On 06/06/2025, the firm sent an "Urgent Medical Device Removal - Immediate Action Required" Letter to customers inform them that, as a result of a comprehensive performance review of the Superion system and have determined that it is not meeting expected performance levels during the implantation procedure which includes breakage of the instrument (e.g., driver tip and insertion tool) and the device (e.g., spindle cap). Customer are instructed to: Physicians should stop all implants of the Superion Indirect Decompression System. Further distribution or use of any remaining affected product should cease immediately. This recall notification does not apply to Superion devices that have already been implanted and they can continue to remain in use. Boston Scientific is not recommending explant of successfully implanted Superion devices. 1. Continue to report all device-related incidents or quality concerns experienced with the Superion Indirect Decompression System to Boston Scientific. 2. Please segregate all Superion Indirect Decompression System product immediately and return it to Boston Scientific in accordance with the enclosed instructions. Complete and return the RVTF to get a Return Goods Authorization (RGA) number. "Indicate the quantity of SINGLE units you will be returning for credit "If you have product that is listed in Attachment 1 (Affected Products) that is not included on your RVTF, provide the material number, lot number, and quantity you intend to return on your RVTF "Return the RVTF via: Email: BSCFieldActionCenter@bsci.com, or Fax: BSC Field Action Center 1-763-415-7708 Public Contact - Renee Archie 508-683-4523 or email Renee.Archie@bsci.com
Initiated
2025-06-06
Root cause
Device Design
Distribution
U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.
Recall number
Z-2485-2025
Recall status
Open, Classified
CDRH record ID
214586
FDA classified
2025-09-02
Recall event number
97109

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗